MANNI, MARIA ELENA
 Distribuzione geografica
Continente #
EU - Europa 922
NA - Nord America 740
AS - Asia 113
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 1.782
Nazione #
US - Stati Uniti d'America 737
PL - Polonia 591
RU - Federazione Russa 137
IT - Italia 68
IE - Irlanda 47
SG - Singapore 35
CN - Cina 29
SE - Svezia 27
DE - Germania 26
HK - Hong Kong 18
FI - Finlandia 15
IN - India 11
TR - Turchia 8
VN - Vietnam 8
GB - Regno Unito 6
CI - Costa d'Avorio 5
JO - Giordania 4
CA - Canada 3
BE - Belgio 2
CH - Svizzera 2
AU - Australia 1
CO - Colombia 1
UA - Ucraina 1
Totale 1.782
Città #
Warsaw 590
Santa Clara 164
Fairfield 89
Chandler 59
Dublin 46
Seattle 43
Woodbridge 41
Ashburn 38
Florence 36
Houston 34
Wilmington 32
Singapore 29
Cambridge 26
Ann Arbor 20
Altamura 16
Lawrence 16
Beijing 13
Princeton 13
Medford 11
Munich 11
Hong Kong 10
Mumbai 10
Dong Ket 8
Kent 8
Boardman 7
Shanghai 6
Abidjan 5
Dearborn 5
Cagliari 4
Helsinki 4
New York 4
San Diego 4
Boston 3
Izmir 3
Jacksonville 3
Moscow 3
Phoenix 3
Brussels 2
Buffalo 2
Grevenbroich 2
Los Angeles 2
Redmond 2
Redwood City 2
Toronto 2
Andover 1
Basel 1
Bern 1
Bethesda 1
Bogotá 1
Brescia 1
Brisbane 1
Cittiglio 1
Cork 1
Dallas 1
Elkins Park 1
Hangzhou 1
Hillsboro 1
Nanjing 1
Nashville 1
Norwalk 1
Ottawa 1
Pisa 1
Poggibonsi 1
Prescot 1
San Mateo 1
Zhengzhou 1
Totale 1.453
Nome #
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 288
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 265
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 265
3-iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse 223
Impact of drug administration route on drug delivery and distribution into the lung: an imaging mass spectrometry approach. 145
Pharmacological characterisation of behavioural and metabolic effects of 3-iodothyronamine (T₁AM) and 3-iodothyroacetic acid (TA1), endogenous end products of thyroid hormone metabolism. 141
Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: implications in heart failure 120
The effect of losartan treatment on the response of diabetic cardiomyocytes to ATP depletion 112
The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity. 111
Monoamine oxidase activity in end-stage heart failure associated with dilated and ischemic cardiomyopathies: a comparison between left and right ventricles 63
Monoamine oxidase in end-stage heart failure associated with dilated and ischemic cardiomyopaties: a comparison between left and right ventricles. 61
Totale 1.794
Categoria #
all - tutte 4.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 0 0 0 38 30 38 41 28 24 30 5
2020/2021193 16 29 3 22 12 19 16 15 16 30 5 10
2021/202281 9 13 3 3 0 4 5 2 1 8 11 22
2022/2023213 19 41 13 12 16 41 29 12 21 1 5 3
2023/202464 4 6 11 6 4 4 0 15 1 0 10 3
2024/2025408 19 61 53 81 194 0 0 0 0 0 0 0
Totale 1.794